TP53 and neoplasm: Lastly, Cluster 3, defined by frequent TP53 mutations, high TMB, and an inflamed immune phenotype, achieved the best therapeutic outcomes, consistent with a hyper-inflamed tumor state that is highly responsive to immune checkpoint blockade.